Printer Friendly

Diagnostic Electrophysiology (EP) Catheters - Global Trends, Estimates and Forecasts, 2012-2018.

NEW YORK, Sept. 9, 2014 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Diagnostic Electrophysiology (EP) Catheters - Global Trends, Estimates and Forecasts, 2012-2018 http://www.reportlinker.com/p02225774/Diagnostic-Electrophysiology-EP-Catheters---Global-Trends-Estimates-and-Forecasts-2012-2018.html

Global Market Watch: Global Diagnostic Electrophysiology Catheters sector is projected to reach US$3.5 billion by 2016. The North America accounts for nearly 34% (2015) of the global value while Europe claims approximately 29% (2018). Asia-Pacific is the fastest growing region with a CAGR of 13.2% driving a market value of US$857 million by 2015. On a global scale, projections for Conventional EP Diagnostic Catheters indicate more than 40% market share leaving the rest of the market to the Advanced and Ultrasound EP Diagnostic Catheters. Healthcare Industry division has been witnessing a drastic change regarding the new innovation and technology which in terms are applied in improving from sector to sector since the past 3-5 years. Cardiovascular industry growth continues to increase with the presence of multiple technologies such as advanced material and software which is featured in most of the devices. International companies tends to innovate, develop new products and to enhance the existing features in cardiovascular devices.

Report Focus: The report 'Diagnostic Electrophysiology (EP) Catheters - Global Trends, Estimates and Forecasts, 2012-2018' reviews the latest trends in cardiovascular devices with a perceptive attempt to disclose the near-future growth prospects. An in-depth analysis on a geographic basis provides strategic business intelligence for healthcare sector investments. The study reveals profitable investment strategies for market start-ups, pharmaceutical/biotechnology companies, laboratories, Contract/Clinical/Commercial Research Organizations (CROs), government/academic organizations, consulting firms, database buyers and many more in preferred locations. The report primarily focuses on: -- Emerging Market Trends -- Advancements in the Technological Space -- Market Demand of The Segments (By-Region) -- Key Growth Areas and Market Size -- Region-Wise Demand Factor -- Key Competitors Edge -- Investment Strategies

The analysis primarily deals with by type. Further, the subdivided categories include: Diagnostic Electrophysiology (EP) Catheters C By Type a. Conventional EP Diagnostic Catheters (fixed and steerable) b. Advanced EP Diagnostic Catheters (loop and other) c. Ultrasound EP Diagnostic Catheters The period considered for the diagnostic electrophysiology catheters market analysis is 2012-2018. The region wise distribution of the market consists of North America (USA and Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Belgium and Rest of Europe), Asia-Pacific (Japan, China, India, New Zealand, South Korea, Australia and Rest of Asia-Pacific)), Latin America (Brazil, Argentina and Rest of Latin America) and Rest of World (South Africa, Middle East and Rest of Rest of World). The market growth rate in the major economies such as the U.S., Japan, China etc. are estimated individually. More than 727 market players are identified in cardiovascular devices industry out of which 122 key companies that project improved market activities in the near future are profiled. The report consists of 141 data charts describing the market shares, sales forecasts and growth prospects. Moreover, key strategic activities in the market including mergers/acquisitions, collaborations/partnerships, product launches/developments are discussed. Estimates are based on online surveys using customized questionnaires by our research team. Besides information from government databases, company websites, press releases & published research reports are also used for estimates.

I. REPORT FOCUS A. INTRODUCTION CARDIOLOGY KINDS OF CARDIAC CONDITIONS A. BLOOD FLOW IN THE HEART B. HEART MALFUNCTION TYPES OF CARDIAC ARREST C. MYOCARDIUM DISORDERS OF MYOCARDIUM D. PERICARDIUM E. HEART VALVES DISORDERS OF HEART VALVES F. CONGENITAL HEART DEFECT TYPES OF CONGENITAL HEART DEFECT G. AILMENTS OF BLOOD VESSELS (VASCULAR DISEASES) H. HEART FAILURE B. CARDIOVASCULAR DEVICES DEVICES FOR ENDOVASCULAR ANEURYSM REPAIR AND REPLACEMENT TECHNIQUES TO PREVENT CORONARY BLOOD VESSEL SYNDROME TOOLS DEPLOYED IN CARDIOLOGY DIAGNOSTIC TESTS AND PROCEDURES CONCLUSION D. DIAGNOSTIC ELECTROPHYSIOLOGY CATHETERS - TYPES - MARKET BRIEFING NORTH AMERICA EUROPE ASIA-PACIFIC LATIN AMERICA REST OF WORLD

CONVENTIONAL EP DIAGNOSTIC CATHETERS II. MARKET ANALYSIS DIAGNOSTIC ELECTROPHYSIOLOGY (EP) CATHETERS C INDUSTRY SNAPSHOT A. DIAGNOSTIC ELECTROPHYSIOLOGY (EP) CATHETERS - SEGMENTATION DIAGNOSTIC ELECTROPHYSIOLOGY (EP) CATHETERS - GLOBAL DIAGNOSTIC ELECTROPHYSIOLOGY (EP) CATHETERS - BY GEOGRAPHY NORTH AMERICA EUROPE ASIA-PACIFIC LATIN AMERICA REST OF WORLD DIAGNOSTIC ELECTROPHYSIOLOGY (EP) CATHETERS C BY TYPE DIAGNOSTIC ELECTROPHYSIOLOGY (EP) CATHETERS - TYPE - BY GEOGRAPHY CONVENTIONAL EP DIAGNOSTIC CATHETERS NORTH AMERICA EUROPE ASIA-PACIFIC LATIN AMERICA REST OF WORLD ADVANCED EP DIAGNOSTIC CATHETERS NORTH AMERICA EUROPE ASIA-PACIFIC LATIN AMERICA REST OF WORLD ULTRASOUND EP DIAGNOSTIC CATHETERS NORTH AMERICA EUROPE ASIA-PACIFIC LATIN AMERICA REST OF WORLD B. GROWTH RATE ANALYSIS GLOBAL DIAGNOSTIC ELECTROPHYSIOLOGY (EP) CATHETERS - MARKET GROWTH RATES GLOBAL DIAGNOSTIC ELECTROPHYSIOLOGY (EP) CATHETERS - TYPE - GROWTH RATES C. INVESTMENT FOCUS III. INDUSTRY OVERVIEW FREQUENT OCCURRENCES OF CARDIOVASCULAR DISEASES WITNESS IMPROVEMENTS IN MEDICAL DEVICES FOR CARDIOVASCULAR APPLICATIONS AN ENCOURAGING JAB FOR TORPID PERIODS A. A REVIEW ON CARDIAC MEDICAL DEVICE TYPES CARDIAC RHYTHM MANAGEMENT DEVICES CRM IN EUROPE CARDIAC DEFIBRILLATORS RAPID GROWTH IN DEFIBRILLATOR SALES CARDIAC PACEMAKER DEVICES THE DATA COLLECTION WORK

CARDIAC RESYNCHRONIZATION THERAPY (CRT) CARDIAC MONITORING AND DIAGNOSTIC DEVICES THE PROGRESSIVE AND FREQUENT OCCURRENCES OF HEART DISEASES TO ENCOURAGE HUGE DEMAND OF DIAGNOSTIC CARDIAC MONITORING SYSTEMS INCORPORATION OF SYSTEMS WITH EMR TO BOOST EXTENDED GROWTH OF MARKET THE NORTH AMERICAN CARDIAC MONITORING DEVICES MARKET OVERVIEW INTERVENTIONAL CARDIAC DEVICES CORONARY STENTS EVOLUTION OF STENT TECHNOLOGY ATTRACTS HUGE ATTENTION FFR IMPACT ON DES MARKET MARKET FORECASTS AN IMPACT OF FFR AND OCT ON THE DES MARKET CARDIAC CATHETERS COMPETITIVE ANALYSIS ELECTROPHYSIOLOGY CATHETERS (EP) GROWTH IN ELECTROPHYSIOLOGISTS IN EUROPE DIAGNOSTIC EP CATHETERS, ABLATION DEVICES SEE STRONG INDUSTRY GROWTH EP MAPPING NEW AF ABLATION DEVICES SEEK APPROVAL ATRIAL FIBRILLATION (AF) INTRAVASCULAR ULTRASOUND (IVUS) GO WITH THE FLOW: FRACTIONAL FLOW RESERVE, THAT IS PERIPHERAL VASCULAR DEVICES ARTERIOTOMY CLOSURE DEVICES EMBOLIC PROTECTION DEVICES (EPD) INFERIOR VENA CAVA (IVC) FILTERS CONCLUSION

PERIPHERAL GUIDEWIRES AV ACCESS THROMBECTOMY DEVICES PROSTHETIC HEART VALVES SWISS CARDIOVASCULAR DEVICES: A MARKET REVIEW MARKET CHALLENGES B. CARDIAC DEVICES: MORTALITY RISKS V/S AGE DRIVERS IN THE MEDICAL IMPLANT INDUSTRY SIZE AND WEIGHT POWER EFFICIENCY PERFORMANCE SPECIFICATIONS RISK MITIGATION AND RELIABILITY EXCITING FUTURE PREDICTED FOR ADVANCED CARDIOVASCULAR DEVICES C. CARDIAC DISEASE: AN ECONOMIC PERSPECTIVE CARDIOVASCULAR DISEASE (CVD) AND ITS EFFECTS ON HEALTH AND ECONOMY IMPACT OF CVD IN EUROPE IMPACT ON NEW YORK STATE ECONOMIC IMPACT OF CVD IN NYS HEALTH AND ECONOMIC IMPACT OF HEART DISEASE PREVENTION IMPACT OF CVD ON ECONOMIC STABILITY ECONOMIC COST OF CARDIOVASCULAR DISEASES COST OF CARDIOVASCULAR DISEASE TO TRIPLE BY 2030 CARDIOVASCULAR DISEASE IS LARGELY PREVENTABLE D. INFECTIOUS AND CARDIOVASCULAR DISEASES IN AFRICA AND BEYOND E. RECENT FDA ACTIONS AND APPROVALS IN CARDIOVASCULAR DEVICES

F. MARKET TRENDS PATIENT ENROLLMENT BY CARDIAC DIMENSIONS IN TITAN II CLINICAL TRIAL CEDARS-SINAI HEART INSTITUTE STUDY: STEM CELLS AUGMENTS HEART'S NATURAL REPAIR SYSTEMS GE HEALTHCARE'S DISCOVERY IGS 730 SYSTEM, AN INNOVATION FOR HYBRID OPERATING ROOMS GE'S AUTOMATED FUNCTION IMAGING FOR DAILY CLINICAL USE. CRYOLIFE RECEIVES EXPANDED INDICATION FOR BIOFOAM IN CARDIOVASCULAR SURGERIES IN EUROPE INNOVATIVE PROCEDURES TO TREAT PERIPHERAL ARTERY DISEASE (PAD) TASK FORCE MONITOR DEMONSTRATED AS EFFECTIVE AUTONOMIC BIOMARKER IN CFS PATIENTS INNOVATION IN INTERVENTIONAL CARDIOLOGY: CATHETER RETRIEVAL OF INFECTIVE FLORA AND MOVABLE CLOTS FROM CARDIAC VALVES AND COMPARTMENTS STEREO-TAXIS UNVEILS LATEST ELECTROPHYSIOLOGY PLATFORM: EPOCH (TM) VICOR TECHNOLOGIES ACQUIRES FDA CLEARANCE OF 510(K) FOR ITS PD2I NONLINEAR ALGORITHM AND SOFTWARE TO BE EMPLOYED IN CARDIOVASCULAR DISEASE TESTING VICOR TECHNOLOGIES ACQUIRES FDA CLEARANCE OF 510(K) FOR ITS PD2I NONLINEAR ALGORITHM AND SOFTWARE TO BE EMPLOYED IN CARDIOVASCULAR DISEASE TESTING STEREO TAXIS REPORTS DEVELOPMENT OF CATHETER STRATEGIC AFFILIATION GLP PRE-MEDICAL STUDIES EXHIBIT NCONTACT ABLATION LESIONS ARE COMPREHENSIVE AND TRANSMURAL MODERNIZATIONS IN INTERVENTIONAL CARDIOLOGY: TECHNOLOGY, FINANCES AND POLITICAL POLICIES B. BRAUN'S INTROCAN SAFETY 3 CLOSED IV CATHETER IS PRESENTED WITH TOP INNOVATION AWARD MID SECURES FIRST TRANCHE OF $5 MILLION SERIES B FINANCING RESEARCH REVEALS THAT HUMAN HEARTS PRODUCES NEW CELLS AFTER BIRTH A NEW TYPE OF NERVE CELL IDENTIFIED IN THE BRAIN ROCHE TO ADVANCE 240 MILLION SWISS FRANCS IN DIAGNOSTICS PRODUCTION IN GERMANY SORIN GROUP ANNOUNCES INVESTMENT IN HIGHLIFE. FIRST 34 U.S. PATIENTS IMPLANTED WITH BIOTRONIK'S NEW EVIA HF-T PACEMAKER. AORTECH LNTERNATIONAL PLC CLAIMS MATERIAL BREACH OF CONTRACT BY DIVISION OF ST. JUDE MEDICAL SPECTRANETICS LAUNCHES U.S COMMENCEMENT OF THE TAPAS(TM) CATHETER AND PRECLINICAL ANIMAL DATA ON DRUG UPTAKE IN PERIPHERAL VESSELS USCOM MAKES PRESENTATIONS AT WORLD HYPERTENSION CONGRESS MORTARA INSTRUMENT, INC. LAUNCHES "BUILT WITH PRIDE IN MILWAUKEE" CAMPAIGN. MALLINCKRODT JOINS PARTNERSHIP AT DRUGFREE.ORG TO INTRODUCE MEDICINE ABUSE PROJECT DRUG-ELUTING STENTS ARE SECURE CARDIAC SCIENCE BEGS TOP RANKING MD BUYLINE'S USER SATISFACTION SURVEY ARTIFICIAL HEART SUCCESSFULLY IMPLANTED IN A BABY IN JAPAN FOR THE FIRST TIME ARTERIAL REMODELING TECHNOLOGIES ANNOUNCES FIRST HUMAN USE OF ITS NEXT-GENERATION BIORESORBABLE STENT ATRIUM MEDICAL CORPORATION RECEIVES PREMIER PERFORMANCE AWARD FOR OPERATIONAL EXCELLENCE. BAYER HEALTHCARE DISCLOSES ADVANCES IN CT CONTRAST DOSE MANAGEMENT(TM) SOLUTIONS. HRS: REMOTE PATIENT MONITORING TO MINIMIZE UNPLANNED ED ADMINS FUTURE HOME HEALTH CARE EQUIPMENT TREND- TECHNOLOGY OUTLOOK FORTUNE MAGAZINE NAMED ST. JUDE MEDICAL AS THE "MOST ADMIRED COMPANY" BIOTRONIK OPENS NEW ASIA PACIFIC HEADQUARTERS IN SINGAPORE COOK MEDICAL TO INVEST[euro]16.5M IN IRISH MEDICAL TECHNOLOGY MARKET MAJOR EVENTS IN CARDIOVASCULAR MEDICAL DEVICE SPACE MEDICAL IMAGING EQUIPMENT OF SIEMENS HEALTHCARE WINS LARGEST ORDER IN LATIN AMERICA. NEGATIVE TRENDS IN INNOVATION IN INTERVENTIONAL CARDIOLOGY DESPITE DECREASES IN CVD MORTALITY-INTERVENTIONAL CARDIOLOGISTS EXPRESS ANGUISH FIRST IMPLANT OF BOSTON SCIENTIFIC'S WATCHMAN DEVICE IN PATIENTS IN LATIN AMERICA STUDY REVEALS THAT BAYER HEALTHCARE'S COTAVANCE DRUG ELUTING BALLOONS WITH PACCOCATH TECHNOLOGY REDUCED TARGET LESION REVASCULARIZATION (TLR) RATES BY 59% IN PAD PATIENTS COMPARED TO THOSE TREATED WITH UNCOATED BALLOONS. USCOM PRESENTED NEW HYPERTENSION MANAGEMENT STUDY AT WORLD HYPERTENSION CONGRESS SAHAJANAND MEDICAL TECHNOLOGIES AWARDED MEDICAL DEVICE COMPANY OF THE YEAR 2011 TERUMO CORPORATION, A WELL KNOWN PIONEER IN MEDICAL DEVICE TECHNOLOGY, CELEBRATES 90TH ANNIVERSARY CARDICA ACHIEVES LANDMARK UNDER DISTRIBUTION AGREEMENT WITH CENTURY MEDICAL SOLUTIONS FOR SUSTAINABLE CARDIOVASCULAR CARE AT THE EUROPEAN SOCIETY OF CARDIOLOGY (ESC) EXCOR PEDIATRIC VENTRICULAR ASSIST DEVICE RECOMMENDED BY FDA ADVISORY PANEL FOR USE IN THE UNITED STATES. ZOLL NOMINATED TO GLOBE 100 AGAIN USCOM ENTERS EUROPEAN MARKETS POSITIVE GROWTH AND OUTLOOK FOR BIOTRONIK IN USA AND OTHER MARKETS USCOM SECURES STRONG PRESENCE IN US AND CANADA CARDIOMEMS AMONG THE TOP 10 INNOVATIVE TECHNOLOGY COMPANIES COVIDIEN INTRODUCES NEW GLOBAL PACKAGING STENTYS'S DRUG-ELUTING STENT RECEIVES MORE REIMBURSEMENT IN GERMANY. SORIN GROUP INTRODUCES THE ACHIEVEMENT OF A KEY MILESTONE IN AORTIC VALVE REPLACEMENT CARDIOMEMS RECEIVES GEORGIA BIO (GABIO) 2011 DEAL OF THE YEAR AWARD USCOM EYES EASTERN EUROPEAN MARKET VCU SUCCESSFULLY TRANSPLANTED 900TH TOTAL ARTIFICIAL HEART INNOVATIVE TRENDS IN RECENT MEDICAL DEVICES INFECTIONS FROM IMPLANTED CARDIAC DEVICES TYRX REACHES MILESTONE IN AIGISRX IMPLANTATION HEART TRANSPLANTS SUBSTITUTED BY A PUMP DEVICES FOR TREATMENT OF ATRIAL FIBRILLATIONS (AF) REMOTE MONITORING OF HEART FAILURE PATIENTS EFFECTS OF REMOTE MONITORING OF IMPLANTED DEVICES OAKWOOD HOSPITAL AND WAYNE STATE UNIVERSITY WORKING ON HEART IMPLANTATION IMPLANTABLE CARDIAC MONITOR WITH HELPFUL APPROACH OVER-THE-COUNTER APPARATUS BOSTON SCIENTIFICS' IMPLANTABLE DEFIBRILLATOR CARDIAC SCIENCE'S NEW CARDIAC TREATMENT THE ONLY SYNCHRONIZED SURGICAL AND CATHETER BASED ATRIAL FIBRILLATION CARDIAC SCIENCE CORPORATION WITH CARDIAC DISEASES HEALING METHOD LOCAL MEDICARE'S COVERAGE FOR HYPERTENSION WITH BIOZ(R) ICG TECHNOLOGY A NEW STANDARD IN CARDIAC SPECT RECONSTRUCTION A REVOLUTIONIZED ELECTROPHYSIOLOGY (EP) FOR CARDIAC LIDCO PRODUCTS ACCEPTED IN SOUTH KOREA INVENTION OF BI-DIRECTIONAL CARDIAC CATHETER FOR IRREGULAR HEART RHYTHMS BEST AND LATEST SELF-TEACHING HEART SOUNDS REPLACING VALVE WITHOUT CARDIAC SUPPORT U.S. FDA GRANTS THE NAVISTAR THERMOCOOL CATHETER FOR RAPID HEART BEAT AN FDA US APPROVED TREATMENT FOR CLOGGED NECK ARTERIES NEW-FANGLED SPECIALTY CATHETER BY ABBOTT AT THE USA MEDICAL IMPLANT MARKETS UNDER THE INFLUENCE OF TECHNICAL TRENDS

G. KEY COMPANY PROFILES NORTH AMERICA EUROPE ASIA-PACIFIC REST OF WORLD OTHER KEY COMPANY INDUSTRY ACTIVITES / PRODUCT LAUNCHES CARDIAC DEVICES MARKETED AND PIPELINE PRODUCTS CARDIAC MEDICAL DEVICES C PATENTS KEY COMPANIES FINANCIAL OVERVIEW IV. INDUSTRY COMPANY DATABASE V. APPENDIX RESEARCH FOCUS ABOUT AXIS RESEARCH MIND DISCLAIMER FEEDBACK

To order this report: Diagnostic Electrophysiology (EP) Catheters - Global Trends, Estimates and Forecasts, 2012-2018 http://www.reportlinker.com/p02225774/Diagnostic-Electrophysiology-EP-Catheters---Global-Trends-Estimates-and-Forecasts-2012-2018.html

__________________________ Contact Clare: clare@reportlinker.com US: (339)-368-6001 Intl: +1 339-368-6001

SOURCE Reportlinker
COPYRIGHT 2014 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2014 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Geographic Code:100NA
Date:Sep 9, 2014
Words:2127
Previous Article:Electrocardiogram (ECG) Devices - Global Trends, Estimates and Forecasts, 2012-2018.
Next Article:KapStone Announces Executive Sale Of Stock.

Terms of use | Copyright © 2017 Farlex, Inc. | Feedback | For webmasters